About Ensysce
Research Programs
Intellectual Property
Announcements
Related Studies
Contact Us
HomeAbout EnsysceContact Us
Recent Announcements
Ensysce’s Bet: Combining Two Risky Drug Technologies That Add Up
READ MORE
Ensysce Biosciences Inc. completes Qualifying Financial Transaction matching Emerging Technology Funds from the State of Texas.
READ MORE
Carbon Nanotubes:
Solution for the Therapeutic Delivery of siRNA?
READ MORE
Single-walled carbon nanotubes provide a safe and effective means for delivery of siRNA
READ MORE
Ensysce Biosciences, Inc. is focused on the use of fullerene carbon nanotubes as delivery agents for cancer therapeutics.
Carbon nanotubes' unique chemical structure allows them to form stable complexes with cancer-cell targeted agents ranging from small interfering RNA (siRNA) to currently existing cancer drugs such as taxol and doxorubicin. Carbon nanotube complexes can carry these active agents into cancer cells as payloads, protecting them during transport, and, importantly, releasing the payload once inside the cancer cells. All of these features make carbon nanotubes ideal for use with many active macromolecules.
Ensysce Biosciences, Inc. is focused on the use of fullerene carbon nanotubes for novel therapeutic applications specifically in the area of cancer treatment. The use of fullerene carbon nanotubes has the goal of solving ...
READ MORE
Ensysce Biosciences is accelerating the use of fullerene carbon nanotubes in therapeutics by funding fundamental discovery research programs at medical centers and universities. Scientists with extensive experience in cancer therapeutics and ...
READ MORE
Copyright © 2014 Ensysce Biosciences Inc. All Rights Reserved
Home|About Ensysce|Contact Us
Research Programs|Intellectual Property|Announcements|Related Studies